Market Overview:
The global ezetimibe API market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of obesity and other lifestyle diseases, rising demand for generic drugs, and growing investments by pharmaceutical companies in R&D activities.
Product Definition:
The Ezetimibe API is a drug that is used to lower cholesterol levels in the blood. It works by blocking the absorption of cholesterol from food in the intestine. This helps to reduce the amount of cholesterol that is circulating in the blood, which can help to prevent heart disease and other health problems.
Purity≥98%:
Purity 98% is a patented, high-performance liquid extracted from African palm oil. It has been used as the standard for measuring the purity of API (Active Pharmaceutical Ingredients) in pharmaceuticals and nutraceuticals industries. Increasing demand for bio-based products coupled with growing R&D expenditure on novel drug development is expected to drive market growth over the forecast period.
Purity
Ezetimibe is used to treat cholesterol abnormalities and to prevent the occurrence of heart-related problems in patients with high cholesterol levels. The drug has been approved by the Food and Drug Administration (FDA) for use as a prescription drug under the category of statins. However, there are certain side effects associated with its usage such as myopathy, rhabdomyolysis, pancreatitis & hepatitis among others that limit its adoption in clinical settings thereby limiting market growth.
Application Insights:
Ezetimibe tablets were the most prominent application segment in the global ezetimibe api market, accounting for over 45% of the total revenue share in 2017. The product is used to reduce cholesterol levels and prevent cardiovascular diseases. It also reduces low-density lipoprotein (LDL) cholesterol levels and increases high-density lipoprotein (HDL) cholesterol levels thereby reducing the risk of heart attack & stroke.
The growing awareness regarding cardiovascular diseases coupled with rising demand for effective treatment options is expected to boost product demand over the forecast period. Furthermore, increasing research & development activities pertaining to new drug formulations that are more convenient, user-friendly as well as cost-effective will further fuel industry growth during this period.
Other applications include usage in diet pills along with other pharmaceutical drugs such as simvastatin.
Regional Analysis:
North America was the largest regional market in 2017 owing to high consumer awareness and presence of key manufacturers. The U.S., in particular, is one of the most lucrative markets for pharmaceutical companies as it has one of the highest per capita income levels and a large patient pool at its disposal. In addition, rising obesity rates are expected to fuel ezetimibe sales over the forecast period.
Asia Pacific is estimated to be fastest-growing region during the forecast period due to growing population, disposable income levels and healthcare expenditure in emerging countries such as China & India and other Southeast Asian nations. Moreover, increasing prevalence of diabetes is also likely to drive product demand over this period since it increases risk for cardiovascular diseases along with kidney failure or damage (nephropathy).
Growth Factors:
- Increasing prevalence of obesity and other lifestyle-related diseases such as diabetes, which is driving the demand for Ezetimibe API.
- Growing awareness about the benefits of Ezetimibe API in reducing the risk of heart disease and other cardiovascular disorders.
- Rising R&D investments by pharmaceutical companies to develop novel therapies using Ezetimibe API.
- Technological advancements that are helping to improve the efficacy and safety profile of Ezetimibe API products.
Scope Of The Report
Report Attributes
Report Details
Report Title
Ezetimibe API Market Research Report
By Type
Purity≥98%, Purity<98%
By Application
Ezetimibe Tablets, Others
By Companies
Dr. Reddy’s Laboratories Ltd., Rochem International Inc, Tecoland Corporation, Teva API, Changzhou Pharmaceutical Factory, Glenmark Pharmaceuticals, Neuland Laboratories, WUHAN ZY PHARMACEUTICAL CO LTD, Lupin Ltd, Saptagir Laboratories, Chongqing Fuan Pharmaceutical, Lusochimica SpA, Nishchem International Pvt. Ltd, Ind Swift Laboratories Limited, Curequest lifescience LLP, SGMR Pharmaceuticals, Kongo Chemical Co., Ltd.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
168
Number of Tables & Figures
118
Customization Available
Yes, the report can be customized as per your need.
Global Ezetimibe API Market Report Segments:
The global Ezetimibe API market is segmented on the basis of:
Types
Purity≥98%, Purity<98%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Ezetimibe Tablets, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Dr. Reddy’s Laboratories Ltd.
- Rochem International Inc
- Tecoland Corporation
- Teva API
- Changzhou Pharmaceutical Factory
- Glenmark Pharmaceuticals
- Neuland Laboratories
- WUHAN ZY PHARMACEUTICAL CO LTD
- Lupin Ltd
- Saptagir Laboratories
- Chongqing Fuan Pharmaceutical
- Lusochimica SpA
- Nishchem International Pvt. Ltd
- Ind Swift Laboratories Limited
- Curequest lifescience LLP
- SGMR Pharmaceuticals
- Kongo Chemical Co., Ltd.
Highlights of The Ezetimibe API Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Purity≥98%
- Purity<98%
- By Application:
- Ezetimibe Tablets
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Ezetimibe API Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Ezetimibe API is a platform that enables developers to access and manage their Ezetimibe data.
Some of the major players in the ezetimibe api market are Dr. Reddy’s Laboratories Ltd., Rochem International Inc, Tecoland Corporation, Teva API, Changzhou Pharmaceutical Factory, Glenmark Pharmaceuticals, Neuland Laboratories, WUHAN ZY PHARMACEUTICAL CO LTD, Lupin Ltd, Saptagir Laboratories, Chongqing Fuan Pharmaceutical, Lusochimica SpA, Nishchem International Pvt. Ltd, Ind Swift Laboratories Limited, Curequest lifescience LLP, SGMR Pharmaceuticals, Kongo Chemical Co., Ltd..
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Ezetimibe API Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Ezetimibe API Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Ezetimibe API Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Ezetimibe API Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Ezetimibe API Market Size & Forecast, 2020-2028
4.5.1 Ezetimibe API Market Size and Y-o-Y Growth
4.5.2 Ezetimibe API Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Purity≥98%
5.2.2 Purity<98%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Ezetimibe Tablets
6.2.2 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Ezetimibe API Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Ezetimibe API Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Purity≥98%
9.6.2 Purity<98%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Ezetimibe Tablets
9.10.2 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Purity≥98%
10.6.2 Purity<98%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Ezetimibe Tablets
10.10.2 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Purity≥98%
11.6.2 Purity<98%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Ezetimibe Tablets
11.10.2 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Purity≥98%
12.6.2 Purity<98%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Ezetimibe Tablets
12.10.2 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Purity≥98%
13.6.2 Purity<98%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Ezetimibe Tablets
13.10.2 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Ezetimibe API Market: Competitive Dashboard
14.2 Global Ezetimibe API Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Dr. Reddy’s Laboratories Ltd.
14.3.2 Rochem International Inc
14.3.3 Tecoland Corporation
14.3.4 Teva API
14.3.5 Changzhou Pharmaceutical Factory
14.3.6 Glenmark Pharmaceuticals
14.3.7 Neuland Laboratories
14.3.8 WUHAN ZY PHARMACEUTICAL CO LTD
14.3.9 Lupin Ltd
14.3.10 Saptagir Laboratories
14.3.11 Chongqing Fuan Pharmaceutical
14.3.12 Lusochimica SpA
14.3.13 Nishchem International Pvt. Ltd
14.3.14 Ind Swift Laboratories Limited
14.3.15 Curequest lifescience LLP
14.3.16 SGMR Pharmaceuticals
14.3.17 Kongo Chemical Co., Ltd.
